Accessibility Menu
GSK Stock Quote

GSK (LSE: GSK)

$16.53
(0.4%)
+0.07
Price as of October 22, 2025, 11:30 a.m. ET

KEY DATA POINTS

Current Price
GBX 1,652.5
Daily Change
(0.4%) +$0.07
Day's Range
GBX 1,623 - GBX 1,657.5
Previous Close
GBX 1,652.5
Open
GBX 1,623
Beta
0.01
Volume
5,702,278
Average Volume
7,965,296
Market Cap
6.6T
Market Cap / Employee
$1,652.50M
52wk Range
GBX 1,242.5 - GBX 1,684.5
Revenue
-
Gross Margin
0.72%
Dividend Yield
3.81%
EPS
GBX 82.94
CAPs Rating
-
Industry
Pharmaceuticals

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

GSK Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
GSK+13.69%+21.75%+4.01%+165%
S&P+15.06%+95.03%+14.29%+407%

GSK Company Info

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Commercial Operations, Research and Development, and Consumer Healthcare. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$7.99B1.3%
Gross Profit$5.82B0.3%
Gross Margin72.89%-0.7%
Market Cap$56.27B-9.8%
Market Cap / Employee$0.82M0.0%
Employees68.6K-2.3%
Net Income$1.65B26.2%
EBITDA$2.87B9.5%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$3.60B21.5%
Accounts Receivable$7.32B0.9%
Inventory6.1K3.6%

Liabilities

Q2 2025YOY Change
Long Term Debt$15.30B12.7%
Short Term Debt$2.05B-39.1%

Ratios

Q2 2025YOY Change
Return On Assets5.84%-1.0%
Return On Invested Capital13.39%-0.8%

Cash Flow

Q2 2025YOY Change
Free Cash Flow$1.62B179.8%
Operating Free Cash Flow$1.88B113.0%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Earnings24.5921.3118.9416.567.38%
Price to Book4.303.924.364.01-11.00%
Price to Sales1.981.781.921.81-9.92%
Price to Tangible Book Value-7.67-7.15-6.76-6.29-11.20%
Price to Free Cash Flow TTM19.3824.8324.8516.45-13.82%
Enterprise Value to EBITDA51.9734.8124.9624.51-15.81%
Free Cash Flow Yield5.2%4.0%4.0%6.1%16.04%
Return on Equity18.5%19.1%22.5%23.5%-21.24%
Total Debt$16.06B$16.99B$18.43B$17.35B2.43%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.